300
Participants
Start Date
June 30, 2006
Study Completion Date
November 30, 2006
hepatitis B vaccine
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Waren
GSK Investigational Site, Altenholz
GSK Investigational Site, Flensburg
GSK Investigational Site, Flensburg
GSK Investigational Site, Flensburg
GSK Investigational Site, Husum
GSK Investigational Site, Bredstedt
GSK Investigational Site, Salzgitter
GSK Investigational Site, Erkrath
GSK Investigational Site, Heiligenhaus
GSK Investigational Site, Kleve-Materborn
GSK Investigational Site, Krefeld
GSK Investigational Site, Willich
GSK Investigational Site, Trier
GSK Investigational Site, Trier
GSK Investigational Site, Schoeneberg - Kuebelberg
GSK Investigational Site, Stuttgart
GSK Investigational Site, Bönnigheim
GSK Investigational Site, Schwäbisch Hall
GSK Investigational Site, Offenburg
GSK Investigational Site, Kehl
GSK Investigational Site, Oberkirch
GSK Investigational Site, Ettenheim
GSK Investigational Site, Tuttlingen
GSK Investigational Site, Munich
GSK Investigational Site, Munich
GSK Investigational Site, Munich
GSK Investigational Site, Tutzing
GSK Investigational Site, Weilheim
GSK Investigational Site, Freising
GSK Investigational Site, Nördlingen
GSK Investigational Site, Landsberg am Lech
GSK Investigational Site, Kaufering
GSK Investigational Site, Bad Saulgau
GSK Investigational Site, Cham
Lead Sponsor
GlaxoSmithKline
INDUSTRY